Aristopharma Ltd

Our Products

Ancor Plus (Bisoprolol Fumarate + Hydrochlorothiazide)

Therapeutic Group : Cardiovascular

Share on facebook
Share on twitter
Share on print
Share on email
Bisoprolol and HCTZ have been used individually and in combination for the treatment of hypertension. The antihypertensive effects of these agents are additive; HCTZ 6.25 mg significantly increases the antihypertensive effect of Bisoprolol. The incidence of hypokalemia with the Bisoprolol and HCTZ 6.25 mg combination is significantly lower than with HCTZ 25 mg. Bisoprolol is a beta1-selective adrenoceptor-blocking agent without significant membrane stabilizing or intrinsic sympathomimetic activities in its therapeutic dose range. Hydrochlorothiazide is a benzothiadiazine diuretic. Thiazides affect renal tubular mechanisms of electrolyte reabsorption and increase excretion of sodium and chloride in approximately equivalent amounts.